BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 26782634)

  • 1. In vitro activities and detection performances of cefmetazole and flomoxef for extended-spectrum β-lactamase and plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae.
    Matsumura Y; Yamamoto M; Nagao M; Tanaka M; Takakura S; Ichiyama S
    Diagn Microbiol Infect Dis; 2016 Apr; 84(4):322-7. PubMed ID: 26782634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmid-Mediated AmpC β-Lactamase and Underestimation of Extended-Spectrum β-Lactamase in Cefepime-Susceptible Elevated-Ceftazidime-MIC Enterobacteriaceae Isolates.
    Nishimura F; Morinaga Y; Akamatsu N; Matsuda J; Kaku N; Takeda K; Uno N; Kosai K; Hasegawa H; Yanagihara K
    Jpn J Infect Dis; 2018 Jul; 71(4):281-285. PubMed ID: 29709981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.
    Yang Q; Zhang H; Cheng J; Xu Z; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Shen D; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H
    Int J Antimicrob Agents; 2015 May; 45(5):485-90. PubMed ID: 25600890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cephalosporin MIC distribution of extended-spectrum-{beta}-lactamase- and pAmpC-producing Escherichia coli and Klebsiella species.
    Kohner PC; Robberts FJ; Cockerill FR; Patel R
    J Clin Microbiol; 2009 Aug; 47(8):2419-25. PubMed ID: 19494061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characteristics of extended-spectrum cephalosporin-resistant Enterobacteriaceae from humans in the community.
    van Hoek AH; Schouls L; van Santen MG; Florijn A; de Greeff SC; van Duijkeren E
    PLoS One; 2015; 10(6):e0129085. PubMed ID: 26029910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
    Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
    J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of ESBL- and AmpC-Producing Enterobacteriaceae from Diseased Companion Animals in Europe.
    Bogaerts P; Huang TD; Bouchahrouf W; Bauraing C; Berhin C; El Garch F; Glupczynski Y;
    Microb Drug Resist; 2015 Dec; 21(6):643-50. PubMed ID: 26098354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of ESBL/AmpC genes and specific clones among the third-generation cephalosporin-resistant Enterobacteriaceae from canine and feline clinical specimens in Japan.
    Maeyama Y; Taniguchi Y; Hayashi W; Ohsaki Y; Osaka S; Koide S; Tamai K; Nagano Y; Arakawa Y; Nagano N
    Vet Microbiol; 2018 Mar; 216():183-189. PubMed ID: 29519514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of AmpC and other beta-lactamases in enterobacteria at a large urban university hospital in Brazil.
    da Silva Dias RC; Borges-Neto AA; D'Almeida Ferraiuoli GI; de-Oliveira MP; Riley LW; Moreira BM
    Diagn Microbiol Infect Dis; 2008 Jan; 60(1):79-87. PubMed ID: 17900845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of extended-spectrum β-lactamase and AmpC β-lactamase-producing Enterobacteriaceae isolated from companion animals in New Zealand.
    Karkaba A; Grinberg A; Benschop J; Pleydell E
    N Z Vet J; 2017 Mar; 65(2):105-112. PubMed ID: 27973988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiological screening is necessary to distinguish carriers of plasmid-mediated AmpC beta-lactamase-producing enterobacteriaceae and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae because of clinical similarity.
    Conen A; Frei R; Adler H; Dangel M; Fux CA; Widmer AF
    PLoS One; 2015; 10(3):e0120688. PubMed ID: 25803720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance phenotype-genotype correlation and molecular epidemiology of Citrobacter, Enterobacter, Proteus, Providencia, Salmonella and Serratia that carry extended-spectrum β-lactamases with or without plasmid-mediated AmpC β-lactamase genes in Thailand.
    Kiratisin P; Henprasert A
    Trans R Soc Trop Med Hyg; 2011 Jan; 105(1):46-51. PubMed ID: 20880563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines.
    Kanamori H; Navarro RB; Yano H; Sombrero LT; Capeding MR; Lupisan SP; Olveda RM; Arai K; Kunishima H; Hirakata Y; Kaku M
    Acta Trop; 2011; 120(1-2):140-5. PubMed ID: 21820398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC β-lactamase-producing clinical Enterobacteriaceae isolates.
    Hombach M; Mouttet B; Bloemberg GV
    J Antimicrob Chemother; 2013 Sep; 68(9):2092-8. PubMed ID: 23633681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae.
    Dallenne C; Da Costa A; Decré D; Favier C; Arlet G
    J Antimicrob Chemother; 2010 Mar; 65(3):490-5. PubMed ID: 20071363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of co-production of plasmid-mediated AmpC beta-lactamase and ESBL in cefoxitin-resistant uropathogenic Escherichia coli.
    Ghosh B; Mukherjee M
    Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1449-54. PubMed ID: 27250633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of extended-spectrum β-lactamase (ESBL)- and pAmpC beta-lactamase-producing Enterobacteriaceae of water samples in Tunisia.
    Ben Said L; Jouini A; Alonso CA; Klibi N; Dziri R; Boudabous A; Ben Slama K; Torres C
    Sci Total Environ; 2016 Apr; 550():1103-1109. PubMed ID: 26871556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of cefmetazole against pyelonephritis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae.
    Doi A; Shimada T; Harada S; Iwata K; Kamiya T
    Int J Infect Dis; 2013 Mar; 17(3):e159-63. PubMed ID: 23140947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-spectrum β-lactamase- and pAmpC-producing Enterobacteriaceae among the general population in a livestock-dense area.
    Wielders CCH; van Hoek AHAM; Hengeveld PD; Veenman C; Dierikx CM; Zomer TP; Smit LAM; van der Hoek W; Heederik DJ; de Greeff SC; Maassen CBM; van Duijkeren E
    Clin Microbiol Infect; 2017 Feb; 23(2):120.e1-120.e8. PubMed ID: 27773759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.